Reich Siegfried 4
4 · Turning Point Therapeutics, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Reich Siegfried
EVP & Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-08+17,303→ 17,303 totalExercise: $140.01Exp: 2031-02-07→ Common Stock (17,303 underlying) - Award
Common Stock
2021-02-08+3,845→ 3,845 total
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]1/48th of the shares vest monthly following February 8, 2021.